WebFeb 9, 2024 · Eliem Therapeutics, Inc., a biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, … WebFind the latest press releases from Eliem Therapeutics, Inc Common Stock (ELYM) at Nasdaq.com. Eliem Therapeutics, Inc Common Stock (ELYM) Press Releases …
Did you know?
WebMar 25, 2024 · SEATTLE and CAMBRIDGE, England, March 25, 2024 /PRNewswire/ -- Eliem Therapeutics, Inc., a company delivering therapies that empower patients to live …
WebMar 6, 2024 · The forward-looking statements made in this press release speak only as of the date of this press release. Eliem expressly disclaims any duty, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Eliem's expectations with regard thereto or any change ... WebNov 14, 2024 · This press release contains forward-looking statements, including, without limitation, statements relating to: the advancement of Eliem’s pipeline; the continued development and clinical and therapeutic potential of ETX-155 and Eliem’s Kv7 channel opener program; the commencement of the referenced Phase 2a trial of ETX-155 in …
WebApr 13, 2024 · SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced the appointment of Robert W. Azelby to its Board of Directors. Mr. WebJan 18, 2024 · SEATTLE and CAMBRIDGE, United Kingdom, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the …
WebOct 5, 2024 · SEATTLE and CAMBRIDGE, United Kingdom, Oct. 05, 2024 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. ( Nasdaq: ELYM ), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the …
WebMay 3, 2024 · On this news, Eliem's stock price fell $3.63 per share, or 55.76% percent, to close at $2.88 per share on April 25, ... More news releases in similar topics. Banking & Financial Services; name change airlinesWeb1 day ago · The MarketWatch News Department was not involved in the creation of this content. SEATTLE, April 13, Apr 13, 2024 (GLOBE NEWSWIRE via COMTEX) -- SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook ... name change ahpraWebMar 25, 2024 · SEATTLE and CAMBRIDGE, England, March 25, 2024 /PRNewswire/ -- Eliem Therapeutics, Inc., a company delivering therapies that empower patients to live on their own terms, officially launched today ... name change agencyWeb1 day ago · On April 13, 2024, the Company issued a press release announcing the appointment of Mr. Azelby. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7. ... name change alameda countyWebMar 31, 2016 · View Full Report Card. Fawn Creek Township is located in Kansas with a population of 1,618. Fawn Creek Township is in Montgomery County. Living in Fawn … name change after marriage serviceWebFeb 9, 2024 · Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition. Company to focus on Kv7.2/3 channel opener program and development of … SEATTLE and CAMBRIDGE, United Kingdom, Aug. 09, 2024 (GLOBE … name change alabama social securityWebMar 7, 2024 · SEATTLE and CAMBRIDGE, United Kingdom, March 07, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company focused on developing novel therapies for... medusky \\u0026 company inc honolulu